Efektivitas Susu Kambing Etawa sebagai Terapi Pendukung dalam Penanganan Tuberkulosis
Abstract
Tuberculosis (TB) remains a global health issue, and effective treatment requires a multidisciplinary approach, including adequate nutrition. Etawa goat milk, rich in protein, medium-chain fatty acids, zinc, and selenium, holds potential in supporting the recovery of TB patients. This study aims to explore the benefits of Etawa goat milk in improving nutritional status and enhancing the immune system of TB sufferers. Etawa goat milk is known to aid in tissue repair, reduce inflammation, and boost immune response through its essential nutrients. Although Etawa goat milk shows potential as an adjunct therapy in TB treatment, stronger clinical evidence is needed to confirm its effectiveness. Further research with clinical trials is required to determine the optimal dosage and administration method.
Downloads
References
HR, M. Z. (2018). Aktivitas Antibakteri Susu Kambing Etawa Terhadap Pertumbuhan Bakteri Escherichia Coli. (n.d.).
Iqbal, S., Haider, Z., & Ahsan, N. (2020). The role of nutrition in the treatment of tuberculosis: A review. Pakistan Journal of Nutrition, 19(1), 7–14.
Lönnroth, K., et al. (2016). Tuberculosis control and elimination: The role of new treatments and diagnostic tools. The Lancet Infectious Diseases, 16(6), 698–709.
Luxemburg, R. (2003). Nutrition and health strategies. New York: HarperCollins.
Moeljanto, R. D. (2002). Khasiat & manfaat susu kambing: susu terbaik dari hewan Ruminansia. AgroMedia.
Prasad, A. S. (2013). Zinc in human health: Effect of zinc on immune cells. Molecular Medicine, 19(1), 14–19.
Ribeiro, A. C., Carvalho, P. M., & Santos, J. M. (2018). Nutritional benefits of goat milk in chronic diseases: A literature review. Journal of Nutritional Science, 7, e56.
World Health Organization (WHO). (2021). Global Tuberculosis Report 2021. Geneva: WHO. https://www.who.int/publications/i/item/9789240037021
Copyright (c) 2025 Farha Dina

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.



